Semaglutide 0.5 mg Dose

Mid-stage GLP-1 titration dose for improved appetite control and weight loss response

Explore 0.5 mg Dose
Important: 0.5 mg is a transitional dose in Semaglutide therapy — not the final therapeutic level for most patients.

What is Semaglutide 0.5 mg?

The 0.5 mg dose of Semaglutide is typically the second step in GLP-1 titration after the 0.25 mg starter phase. It increases therapeutic activity while maintaining tolerability.

At this stage, patients usually begin to experience:
  • Stronger appetite suppression
  • Reduced food cravings
  • Early weight loss signals
  • Improved satiety after meals

Effects of 0.5 mg Dose

  • Noticeable reduction in hunger levels
  • More consistent calorie reduction
  • Early fat loss progression begins
  • Improved glycemic stability

What to Expect (Weeks 4–8)

During the 0.5 mg phase, most users report:
  • Gradual weight reduction begins
  • Mild gastrointestinal side effects may persist
  • Better appetite control vs 0.25 mg
  • Improved adherence to dietary changes

Start or Continue Semaglutide Treatment

Access treatment plans, dosage guidance, and provider options for GLP-1 therapy.

Check Treatment Options
View Pricing
Medical supervision is recommended for dose adjustments.

Next Step in Treatment

FAQ

Yes, 0.5 mg provides stronger appetite suppression and early weight loss effects.

Typically 4 weeks before increasing to 1 mg depending on tolerance and response.

Yes, many patients begin to see measurable weight loss at this stage.

Semaglutide Dosage Structure